Greiner Bio-One acquires 3D Cell Culture Technology assets from Nano3D Biosciences
Greiner Bio-One North America, Inc. has acquired 3D cell culture technology previously owned by Nano 3D Biosciences, Inc. As an international distributor of these products since 2016, Greiner Bio-One has now taken the initiative to become a premier provider of this technology worldwide.

Greiner Bio-One Magnetic 3D Cell Culture Products
Greiner Bio-One International GmbH
Magnetic 3D cell culture has become a disruptive technology in the research marketplace by offering an improved method for growing cells and driving results in new pathways to disease treatment and prevention.
Heinz Schmid, CEO of Greiner Bio-One BioScience commented on this strategic acquisition: “The potential for growth in the 3D cell culture market is amazingly vast with laboratories and research facilities utilising this new technology daily to find cures for disease and improve the existing cell culture methodology. The acquisition of a magnetic 3D cell culture technology is just one of Greiner Bio-One’s ongoing efforts to advance scientific research and improve health, while providing researchers access to the best products.”
Nano3D Biosciences, Inc. President and Chief Scientific Officer, Glauco Souza: "We are delighted to have completed this acquisition with Greiner Bio-One. The synergy between Nano3D's technology and Greiner Bio-One’s innovation in tissue culture makes this an excellent match to further advance magnetic 3D cell culture."
Topics
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Cell culture technology
Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.

Topic world Cell culture technology
Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.